Literature DB >> 2948187

Endogenous retroviruses lead to the expression of a histocompatibility antigen detectable by skin graft rejection.

M P Colombo, R Jaenisch, P J Wettstein.   

Abstract

Mov mouse strains differ from their respective, coisogenic partner strains by the embryonic, germ-line introduction of Moloney murine leukemia virus genomes. The possibility that retroviral insertions into the mouse genome resulted in gain or loss mutations at non-H-2 histocompatibility loci was investigated by reciprocal skin grafting between Mov mice and mice from coisogenic, background strains. Two B6-derived and eight 129-derived Mov strains were analyzed. B6 mice rejected skin from the viremic Mov-3 and Mov-14 strains, indicating that these mice had new histocompatibility antigens. No rejections were observed with reciprocal skin grafts exchanged between mice of the 129 background strain and 129-derived Mov strains, one of which (Mov-9) is viremic. To investigate the potential viral origin of the new histocompatibility antigen in Mov-14, lymphocytes from B6 mice primed in vivo with Mov-14 cells or skin were restimulated in vitro with Mov-14 spleen cells and with two retroviral-induced B6 lymphomas, MBL-2 and RBL-5. All three cell types stimulated cytotoxic lymphocytes that lysed Mov-14 Con A lymphoblasts, MBL-2 and RBL-5. The same cytotoxic lymphocytes lysed only lymphoblasts from the viremic Mov-9 strain when tested on cells from 129 and 129 Mov mice. Thus the insertion and expression of exogenous Moloney murine leukemia virus results in the appearance of a new histocompatibility antigen as defined by its stimulation of skin-graft rejection and cytotoxic effector T-cell generation. The non-H-2 histocompatibility antigen identified in this study has been designated H-43 and is encoded by genes mapping to different loci in different Mov strains. These observations suggest that at least a subgroup of non-H-2 histocompatibility antigens is encoded by endogenous retroviruses; the implications of these results for understanding the origin and the identity of non-H-2 histocompatibility antigens are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2948187      PMCID: PMC304168          DOI: 10.1073/pnas.84.1.189

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Construction and recovery of viable retroviral genomes carrying a bacterial suppressor transfer RNA gene.

Authors:  L I Lobel; M Patel; W King; M C Nguyen-Huu; S P Goff
Journal:  Science       Date:  1985-04-19       Impact factor: 47.728

2.  Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.

Authors:  W S Hayward; B G Neel; S M Astrin
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

3.  Association of endogenous viral loci with genes encoding murine histocompatibility and lymphocyte differentiation antigens.

Authors:  D Meruelo; A Rossomando; M Offer; J Buxbaum; A Pellicer
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

4.  Embryonic lethal mutation in mice induced by retrovirus insertion into the alpha 1(I) collagen gene.

Authors:  A Schnieke; K Harbers; R Jaenisch
Journal:  Nature       Date:  1983 Jul 28-Aug 3       Impact factor: 49.962

5.  X chromosome-linked transmission and expression of retroviral genomes microinjected into mouse zygotes.

Authors:  C Stewart; K Harbers; D Jähner; R Jaenisch
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

6.  Heritable histocompatibility changes: lysogeny in mice?

Authors:  D W Bailey
Journal:  Transplantation       Date:  1966-07       Impact factor: 4.939

7.  Endogenous xenotropic murine leukemia virus-related sequences map to chromosomal regions encoding mouse lymphocyte antigens.

Authors:  J C Wejman; B A Taylor; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

8.  Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences.

Authors:  D Wolf; V Rotter
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

9.  Expression of H-2 and viral antigens and resistance to the antitumor lysis of tunicamycin-treated MBL-2 lymphoma cells.

Authors:  M P Colombo; M A Pierotti; D Ballinari; G Parmiani
Journal:  Immunobiology       Date:  1983-08       Impact factor: 3.144

10.  Chromosomal position and activation of retroviral genomes inserted into the germ line of mice.

Authors:  R Jaenisch; D Jähner; P Nobis; I Simon; J Löhler; K Harbers; D Grotkopp
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

View more
  7 in total

1.  The genetic origin of minor histocompatibility antigens.

Authors:  D C Roopenian; G J Christianson; A P Davis; A R Zuberi; L E Mobraaten
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

2.  Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of beta-galactosidase.

Authors:  H G Rammensee; H Schild; U Theopold
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Histocompatibility antigen changes associated with pink-eyed dilute (p) mutations.

Authors:  P J Wettstein; V Chapman; E Birkenmeier
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. V. Chromosomal mapping of the immunodominant cytotoxic T-cell target-1 (CTT-1).

Authors:  M Vagliani; C Melani; G Parmiani; P D'Eustachio; P J Wettstein; M P Colombo
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  Inheritance of a mutant histocompatibility gene and a new mammary tumor virus genome in the B6.KH-84 mouse strain.

Authors:  M P Colombo; R W Melvold; P J Wettstein
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.

Authors:  S Shenoy; K Desch; B Duffy; P Thorson; T Mohanakumar
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

7.  SV40 T-antigen is a histocompatibility antigen of SV40-transgenic mice.

Authors:  P J Wettstein; L Jewett; S Faas; R L Brinster; B B Knowles
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.